We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFCG
12676
AFC Gamma
AFCG
$72.1M
-140,206
Closed -$1.64M
AFIF icon
12677
Anfield Universal Fixed Income ETF
AFIF
$228M
-255,479
Closed -$2.36M
AFRM icon
12678
Affirm
AFRM
$26.2B
-1,461,836
Closed -$39.8M
AGL icon
12679
Agilon Health
AGL
$1.63B
-4,125
Closed -$2.09M
AGX icon
12680
Argan
AGX
$8.11B
-8,688
Closed -$353K
AHG
12681
Akso Health Group
AHG
$1.09B
-36,856
Closed -$62K
AIR icon
12682
AAR Corp
AIR
$5.85B
-9,335
Closed -$436K
AIVL icon
12683
WisdomTree US AI Enhanced Value Fund
AIVL
$440M
-22,072
Closed -$2.19M
AIV
12684
PUT
Aimco
AIV
$383M
-11,800
Closed -$86K
AKYA
12685
PUT
DELISTED
Akoya BioSciences
AKYA
-11,500
Closed -$126K
ALEC icon
12686
PUT
Alector
ALEC
$219M
-15,200
Closed -$217K
ALEX
12687
DELISTED
Alexander & Baldwin
ALEX
-72,629
Closed -$1.68M
ALG icon
12688
CALL
Alamo Group
ALG
$2.01B
-1,800
Closed -$259K
ALGS icon
12689
PUT
Aligos Therapeutics
ALGS
$43M
-640
Closed -$34K
ALK icon
12690
Alaska Air
ALK
$5.13B
-1,821,081
Closed -$88.9M
ALLO icon
12691
PUT
Allogene Therapeutics
ALLO
$708M
-19,800
Closed -$180K
ALLT icon
12692
CALL
Allot
ALLT
$383M
-10,400
Closed -$84K
ALTG icon
12693
CALL
Alta Equipment Group
ALTG
$237M
-16,600
Closed -$205K
AMCR icon
12694
PUT
Amcor
AMCR
$21.3B
-6,660
Closed -$377K
AME icon
12695
PUT
Ametek
AME
$58.4B
-2,400
Closed -$320K
AMH icon
12696
CALL
American Homes 4 Rent
AMH
$12.3B
-8,000
Closed -$320K
GOLD
12697
Gold.com Inc
GOLD
$1.28B
-30,080
Closed -$1.08M
AMRX icon
12698
PUT
Amneal Pharmaceuticals
AMRX
$6.32B
-70,800
Closed -$295K
ANGL icon
12699
CALL
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
-8,800
Closed -$268K
ANGO icon
12700
PUT
AngioDynamics
ANGO
$655M
-10,100
Closed -$218K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.